Envista (NVST) Q3 2026 Earnings Call Transcript
Envista (NVST) reported Q3 2026 core sales growth of 2.7%, adjusted EBITDA growth of 9%, and adjusted EPS growth of 25%. The company raised its full-year 2026 guidance, expecting core growth of 3.75% to 4.25% and adjusted EPS of $1.54 to $1.58. China's market saw a low double-digit contraction due to VBP preparations. The company highlighted product innovations and strong operational performance.
How this was made
The 30-second read
Why it matters
Guidance raise is the primary market-moving element; other operational details reinforce the positive narrative.
Market read
Guidance upgrade may trigger short-term buying pressure and influence sector sentiment.
What to watch
Potential headwinds from macro uncertainty in the U.S. may dampen demand despite guidance lift.
Background
Envista's Q3 2026 earnings call provided operational highlights and a revised full-year outlook.
Ticker impact
Envista raised its full-year 2026 adjusted EPS guidance to $1.54‑$1.58, up >10% at the midpoint, and lifted core sales and EBITDA growth outlook.
likely upside as market prices in higher profit expectations
The new EPS range exceeds prior guidance by >10% and is disclosed for the first time, providing fresh material for valuation models.
Market effects
Dental equipment sector may see broader uplift as peers' guidance is revised upward.
Developing markets exposure could attract investors seeking growth outside the US.
Modest, limited to healthcare equipment niche.
Counterpoint
If the VBP impact in China materializes slower than expected, upside could be limited.
Key entities
- CompanyEnvista Holdings Corp.
Dental equipment and services provider.
